Navigation Links
Medizone Expects OTCBB Listing

SAN FRANCISCO, Aug. 5 /PRNewswire-FirstCall/ -- Medizone International, Inc. (Pink Sheets: MZEI) announced that a market maker has filed the required documentation to list the company on the Over The Counter Bulletin Board (OTCBB). The company is currently listed as a full SEC reporting company on the Pink Sheets and expects to achieve a listing on the OTCBB before the end of August 2009.

Medizone will hold its annual meeting of shareholders on August 26, 2009 in Reno, Nevada. At the meeting, officials of the company will update shareholders on the company's business and shareholders will vote on matters presented by the proxy statement on file with the Securities and Exchange Commission and made available electronically to the company's shareholders. In addition to voting on the election of directors, for the first time since the company became a public company in 1986 the shareholders will vote to increase the number of shares the company is authorized to issue. As noted in the proxy statement, the company has historically relied on the sale of its common stock to finance its operations and research and development. A modest portion of the newly authorized shares would facilitate the financing of hospital beta testing and initial production of the company's AsepticSure hospital sterilization system. "Importantly," noted Edwin Marshall, CEO of the company, "the availability of increased authorized capital will also give management greater flexibility for strategic development and other transactions."

Marshall further clarified the business strategy, "Medizone is preparing a transition into the hospital beta testing stage. We now expect to begin hospital testing during October using production prototype equipment. We are targeting initial sales before the end of this year with deliveries during the first quarter of 2010 expected to bring the company to a break-even cash flow. Our initial production rates will be kept on the conservative side until the design proves very reliable in the field and a dramatic increase in production would not offer significant risk. At that point in time we will have optimized our strengths as a research and development company and expect to partner with a multinational corporation in the hospital sector for increased manufacturing capacity, sales and service. The target is to achieve profitability moving into mid-year 2010."

Medizone International, Inc., is a research and development company engaged in developing its AsepticSure(TM) technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. Current trials will now be expanded to include a hospital mock-up and then hospital beta testing of the production prototype. Initial sales are currently targeted to commence by the end of this year.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

    Investor Relations: 800-953-3350 / web site:
    E-mail: operations @

SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
2. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
3. Medizone Announces a Second Round of Trials Have Begun.
4. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
5. Medizone International, Inc. (MZEI.PK) Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park, Queens University at Kingston, Ontario, Canada.
6. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
7. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
8. ATS Medical Expects Fourth Quarter Revenue to Increase by Approximately 32%
9. NightHawk Radiology Holdings, Inc. Announces Preliminary Results of Its Tender Offer; NightHawk Expects to Purchase 2,367,438 Shares of Its Common Stock at $8.05 per Share
10. Chubb Expects to Release Earnings on July 24 and Hold Conference Call on the Same Day
11. ATS Medical Expects Second Quarter Revenue of $16.7 to $16.9 Million
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone ... member, close friend, or animal pass away, death lives among us. It is your ... Coming from a family of 11 children, author T Sky understands that she may ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... IL (PRWEB) , ... November 30, 2015 , ... The ... an emerging pharmaceutical company. Because it is so important to this key industry segment, ... Factors in your IND Filing” on December 4th at 11am EST. , Federal law ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. ... Surgical Mesh technology for soft tissue repair in the US via Insightra’s national ... resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... & Laser Center is one of a select few plastic surgeons in the ... non-surgical fat removal. , SculpSure™ is the world’s first heat-induced laser treatment for ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- Booth #4303 – The Imaging Components business of Varian ... array of products in a new booth (#4303) at the ... America in Chicago this ... components "At the Heart of Imaging." Products will include a ... Claymount brand, and computer-aided diagnostic software from MeVis as well ...
(Date:11/30/2015)... -- Hanger, Inc. (NYSE: HGR ) (the "Company") today ... its previously announced consent solicitation (as amended and restated, ... amount 7⅛% Senior Notes due 2018 (the "Notes") to ... pursuant to the Consent Solicitation, (ii) the proposed increased ... date of the Consent Solicitation.    ...
(Date:11/30/2015)... , Nov. 30, 2015   VolitionRx Limited (NYSE ... diagnostic tests for a broad range of cancer types and ... LD Micro Conference, which will be held December 1 - 3 ... from VolitionRx will be David Kratochvil , Chief Financial ... of Investor Relations. ® blood-based tests for ...
Breaking Medicine Technology: